ea0063p667 | Interdisciplinary Endocrinology 1 | ECE2019
Riikonen Reetta
, Karimaa Mari
, Rasanen Kati
, Ramela Meri
, Vehmaan-Kreula Pirjo
, Rummakko Petteri
, Wohlfahrt Gerd
, Mustonen Mika V.J.
, Oksala Riikka
Background: Prostate cancer is a major global challenge due to the increasing number of aging population and frequency of diagnosis. During the past decade new treatments have been targeted to the androgen signaling axis either by inhibiting the binding of androgens to androgen receptor (AR) and AR nuclear translocation, or by inhibiting androgen production via CYP17A1 enzyme. Despite the significant progress on the research and new therapies, CRPC is still incurable and there...